Navigating Non-Product Software Validation in GxP Environments

Navigating Non-Product Software Validation in GxP Environments

Yashaswini Maregowda

May 11, 2026

Table of Contents

  1. Introduction
  2. What Is Non-Product Software?
  3. Overlapping Common Expectations
  4. Conclusion

1. Introduction

When life sciences organizations talk about software validation, the conversation always gravitates toward product software, embedded device firmware, or clinical trial software that touches the regulated product directly.

There is an equally important category of GxP software that underpins every regulated operation: non-product software. It includes laboratory information management systems (LIMS), quality management systems (QMS), document management platforms, training systems, and AI-driven analytical tools. Even without being part of the product itself, this software must still be validated.

What this blog covers

Your roadmap through this post

  1. Common Expectations
  2. Why It Matters
  3. Practical Roadmap

2. What Is Non-Product Software?

Non-product software is any software used in a GxP-regulated environment that does not become part of the product and is not embedded in a medical device. Despite this distinction, it directly influences product quality, patient safety, and data integrity, which is precisely why it falls within the scope of regulatory oversight.

Examples include:

3. Overlapping Common Expectations

Common Expectations

The 10 Common Expectations

  1. Risk-Based Validation & Classification
  2. Requirements Management & Lifecycle Traceability
  3. Change Control & Impact Assessment
  4. Audit Trail & Electronic Records Integrity
  5. Testing Strategy Proportionate to Risk
  6. Document Lifecycle & Version Control
  7. Role-Based Access Control (RBAC)
  8. Incident Management & CAPA
  9. Vendor & Supplier Qualification
  10. Periodic Review & Continued State of Control

Risk-Based Validation & Classification

Requirements Management & Full Lifecycle Traceability

Change Control & Impact Assessment

Audit Trail, Data Integrity & Electronic Records

Every GxP electronic record created, modified, or deleted by a non-product software system must be captured in a secure, computer-generated audit trail.

Testing Strategy Proportionate to Risk

Document Lifecycle Management & Version Control

Every non-product software system must have a controlled, complete, and current validation package.

Access Control, User Roles & Permissions

The access control framework for non-product software must be role-based, documented, and auditable.

Incident Management, CAPA & Deviation Handling

Incident management SOP must explicitly address software and AI system incidents, not just process deviations.

Vendor & Supplier Qualification

Supplier qualification program must be comprehensive, risk-prioritized, and regularly maintained.

Periodic Review & Continued State of Control

Periodic review must define review frequency by system risk category, the data and metrics reviewed, the criteria for determining a system is in a state of control.

4. Conclusion

The four frameworks examined here, FDA CSA, the FDA AI Guidance for Drugs and Biologics, GAMP5, and ISO 13485, converge on the same core expectations: risk-based classification, requirements traceability, change control, data integrity, and periodic review. Organizations do not need four compliance programs. They need one program built on this shared architecture, with extensions where a specific framework imposes additional requirements.